Griscelli syndrome

Griscelli syndrome

Overview

Griscelli syndrome is a rare, autosomal recessive disorder that causes partial albinism and can lead to severe neurological or immunological problems. It is characterized by hypopigmentation, resulting in a silvery-gray sheen to the hair, and is caused by genetic mutations affecting melanosome transport. There are three types of the syndrome, distinguished by their specific genetic cause and whether they primarily involve neurological impairment (Type 1), severe immunodeficiency (Type 2), or only hypopigmentation (Type 3).  

Symptoms

Hypopigmentation: The most consistent feature is a silvery-gray sheen to the hair, and some individuals may have hypopigmented skin. 

Large, clumped pigment in hair shafts: Microscopic examination of hair shafts shows large, irregular clumps of pigment instead of a uniform distribution. 

Neurological impairment (Type 1): May include features like ataxia, seizures, and developmental delay. 

Severe immunodeficiency (Type 2): Leads to recurrent infections and life-threatening episodes of hemophagocytic lymphohistiocytosis (HLH). 

Other symptoms: Patients can also have hepatosplenomegaly (enlarged liver and spleen), pancytopenia (low blood cell counts), and hepatitis. 

All types

Hypopigmentation: The skin is paler than normal. 

Silvery-gray hair: The hair has a characteristic silvery-gray sheen due to large clumps of pigment in the hair shafts. 

Type 1 (Elejalde syndrome) 

Neurological issues: These are prominent features and can include:

Delayed motor development

Intellectual disability

Seizures

Weak muscle tone (hypotonia)

Vision and eye abnormalities 

Type 2

Immune system problems: This is the main distinguishing feature.

Hemophagocytic lymphohistiocytosis (HLH): An uncontrolled immune response that can be triggered by infections.

Recurrent infections

Swollen lymph nodes, liver, and spleen (hepatosplenomegaly)

Abnormalities in blood counts (pancytopenia)

Neurological symptoms: Can occur due to immune cells infiltrating the brain. 

Type 3

Only hypopigmentation: This type only affects the hair and skin's pigment, with no significant immune or neurological involvement. 

Causes

Griscelli syndrome type 1: Caused by mutations in the \(MYO5A\) gene. This gene provides instructions for making the myosin Va protein, which is involved in moving vesicles in both melanocytes (pigment cells) and neurons.  Griscelli syndrome type 2: Caused by mutations in the \(RAB27A\) gene. This gene encodes a protein that helps transport vesicles, and its defect in Type 2 leads to severe immune dysfunction, specifically a type of immune deficiency called hemophagocytic lymphohistiocytosis (HLH).  Griscelli syndrome type 3: Caused by mutations in the \(MLPH\) gene. This gene codes for melanophilin, a protein that works with Rab27a and myosin Va to transport melanosomes. This type is characterized by hypopigmentation but not the severe immune or neurological issues seen in the other types. 

Diagnosis

Clinical examination

Physical appearance: Look for the characteristic silvery-gray hair and hypopigmented (light) skin.

Neurological and immunological signs: Assess for neurological issues in type 1 (like developmental delay) or signs of immunodeficiency (like recurrent infections) in type 2. 

Microscopic hair shaft analysis 

Light microscopy: This is a critical step for initial diagnosis. Examine hair shafts for large, clumped, and irregularly distributed pigment granules, particularly in the medulla, which are different from the evenly distributed granules in normal hair.

Polarized light microscopy: This can provide more specific diagnostic clues. GS hairs often appear uniformly white, whereas in Chediak-Higashi syndrome, they show polychromatic refringence, note Orphanet and National Institutes of Health. 

Genetic testing

Molecular genetic testing: This is necessary to confirm the diagnosis and determine the specific type of GS.

GS Type 1: Caused by mutations in the MYO5A gene.

GS Type 2: Caused by mutations in the RAB27A gene.

GS Type 3: Caused by mutations in the MLPH gene. 

Other laboratory tests

Blood tests: In type 2 GS, blood tests may show signs of immune system dysfunction, such as a decreased number of natural killer (NK) cells or T-cells, and can help diagnose conditions like hemophagocytic lymphohistiocytosis (HLH).

Differential diagnosis: GS is distinguished from similar conditions like Chediak-Higashi syndrome, which is characterized by the presence of giant granules in granulocytes, a finding absent in GS. 

Treatment

Griscelli syndrome type 1 (GS1)

Treatment: Supportive care only.

Focus: Managing the neurological complications. 

Griscelli syndrome type 2 (GS2)

Treatment: The only curative treatment is hematopoietic stem cell transplantation (HSCT) or bone marrow transplantation (BMT).

Importance: Early transplantation offers the best outcomes, as the hemophagocytic lymphohistiocytosis (HLH) is often fatal without it.

Palliative care: Immunosuppressive therapy (e.g., high-dose methylprednisolone, cyclosporine, etoposide) can be used to stabilize the patient or induce remission until a transplant can be performed. 

Griscelli syndrome type 3 (GS3)

Treatment: No specific treatment is needed as it only involves pigmentary dilution without neurological or immunological issues.

Focus: Monitoring and managing any related symptoms that may arise. 

Type of Doctor Department :  A pediatric hematologist-oncologist